← All trials
NCT01899677
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2013
- Primary completion
- Sep 1, 2013
- Completion date
- Sep 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 70
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Zeynep Kamil Maternity and Childen Education and Training HospitalLead sponsor
- Zeynep Kamil Maternity and Childen Education and Training HospitalOverall official - principal investigator
- Zeynep Kamil Maternity and Childen Education and Training HospitalStudy director
- Zeynep Kamil Maternity and Childen Education and Training HospitalStudy chair
- Zeynep Kamil Maternity and Childen Education and Training HospitalReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.